Penumbra System
Device Neurointervention
General payments
$2,102,847
Research payments
$813,825
Through program year 2020, $2,102,847 in general payments and $813,825 in research payments were reported against Penumbra System (Neurointervention).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
4 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2020 | General | $523,805 | 862 |
| 2020 | Research | $648,825 | 9 |
| 2019 | General | $1,579,043 | 3,663 |
| 2019 | Research | $165,000 | 3 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2020.
The top 5 of 16 specialties; each share is of general payments naming this product to practitioners with a specialty in 2020. Each practitioner is counted under their primary specialty.
The top 5 of 42 states; each share is of general payments naming this product in 2020 where a state was reported.
Records
4,525 general · 12 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.